Cargando…
Genetic in situ engineering of myeloid regulatory cells controls inflammation in autoimmunity
The ability of myeloid regulatory cells (MRCs) to control immune responses and to promote tolerance has prompted enormous interest in exploiting them therapeutically to treat inflammation, autoimmunity, or to improve outcomes in transplantation. While immunomodulatory small-molecule compounds and an...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599636/ https://www.ncbi.nlm.nih.gov/pubmed/34437913 http://dx.doi.org/10.1016/j.jconrel.2021.08.040 |